Targeting SUMOylation triggers interferon-Ã-dependent activation of patient and allogenic Natural Killer cells in preclinical models of Acute Myeloid Leukemia.
在急性髓系白血病的临床前模型中,靶向 SUMO 化可触发患者和同种异体自然杀伤细胞的干扰素-α 依赖性激活
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-25-0504
Hallal Rawan, de Toledo Marion, Tempé Denis, Berrahouane Rayane, Zemiti Sara, Coënon Loïs, Gitenay Delphine, George Simon, Schüssler Moritz, Laguette Nadine, Bonnet Sarah, Gabellier Ludovic, Cartron Guillaume, Pelegrin Mireia, Villalba Martin, Bossis Guillaume